BIOMARKERS FOR MONITORING GYNECOLOGIC MALIGNANCIES
Journal: International journal of ecosystems and ecology science (IJEES) (Vol.11, No. 3)Publication Date: 2021-07-30
Authors : Suela Bushi Artan Trebicka;
Page : 495-500
Keywords : cancer; hematobiochemical parameters; tumor markers;
Abstract
Tumor markers are playing an increasingly important role in cancer detection and management. These laboratory-based tests are potentially useful in screening for early malignancy, aiding cancer diagnosis, determining prognosis, surveillance following curative surgery for cancer, up front predicting drug response or resistance, and monitoring therapy in advanced disease. Tumor marker assays, CA15-3, CA 125, and CEA are valuable biomarkers for the differential diagnosis of patients with breast and ovarian cancer providing their well-known profiles of sensitivity and specificity and thus demonstrated their reliability for routine laboratory diagnostics. The aim of the study is to evaluate the hematological, biochemical and tumor markers changes changes in gynecologic malignancies after chemotherapy. Significant decrease of CA 125, CA 125 and CEA was observed in all three types of Ca following the second cycle of chemotherapy (p <0.01). The values of hemato-biochemical parameters and tumor markers are important in identifying the course of therapy.
Other Latest Articles
- ESTIMATING OF ROAD ACCIDENTS DURING THE COVID-19 PANDEMIC YEAR IN ALBANIA
- ASSESSMENT OF THE QUALITY OF MINERAL WATER, POKLEK AND VERBOC SPRINGS, IN THE AREA OF GLLOGOC, THROUGH PHYSICO-CHEMICAL ANALYSIS
- THE INDICATOR OF ABUNDANCE (N INDIVIDUALS/FISH) AND THE SPECIES DIVERSITY INDEX (D) FOR PARASITIC FAUNA IN SOME FISHES OF OHRID LAKE
- Congenital absence of penis (Aphallia) – A rare occurrence
- Isolated neurological symptoms in a teenager with COVID-19
Last modified: 2021-07-13 23:52:52